[1]Menghin,Sonja;Pertz,HeinzH.;Kramer,Kai;Seifert,Roland;Schunack,Walter;Elz,Sigurd[JournalofMedicinalChemistry,2003,vol.46,#25,p.5458-5470]
[1]Patent:US2003/144263,2003,A1
102676-61-9
102676-60-8
16832-24-9
199119-46-5
200927-02-2
274927-61-6
1612-76-6 | 5-Phenyl-1,3,4-oxadiazol-2-amine | AA001S6G | MFCD00126383
16197-90-3 | Gamma-chlorocrotonic acid | AA001SI6 | MFCD19228094
1621686-10-9 | 2-Amino-4,4-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-5-one | AA001SRB | MFCD28155162
16250-08-1 | 2-Aminopyridine-5-sulfonic acid | AA001T3Z | MFCD00160315
1628733-94-7 | 1-Azetidinecarboxylic acid, 3-(2,2,2-trifluoro-1-hydroxyethyl)-, 1,1-dimethylethyl ester | AA001TFL | MFCD30723475
1631-52-3 | 1,2-Dithiolan-4-amine, N,N-dimethyl-, ethanedioate (1:1) | AA001TOU | MFCD00210334
16344-24-4 | 2-Anilinonicotinic acid | AA001U1V | MFCD00128791
163810-26-2 | 2-Oxazolidinone, 3-(4-methyl-1-oxopentyl)-4-(phenylmethyl)-, (4R)- | AA001UBJ | MFCD03419264
164161-49-3 | Methyl 5-benzyloxy-4-methoxy-2-nitrobenzoate | AA001UM4 | MFCD17168894
1646152-53-5 | 4-(Indolin-5-yl)morpholine hydrochloride | AA001UWQ | MFCD28369478